Skip to main content
. 2014 Dec;21(6):309–317. doi: 10.3747/co.21.1647

TABLE II.

Most common adverse events with sunitinib 37.5 mg by continuous daily dosing

Event Event occurrence (%)

Escudier et al., 200926 (rcc) George et al., 200921 (gist) Novello et al., 200928 (nsclc) Raymond et al., 201127 (pancreatic net)
Diarrhea 75 40 34 59
Nausea 37 27 40a 45
Asthenia 79b 37 60b 34
Vomiting 27 23 40a 34
Fatigue 79b 33 60b 32
Hair colour change 34 22 29
Neutropenia 45 57 9c 29
Abdominal pain 23 18 28
Hypertension 44 28 28 26
Hand–foot syndrome 49 25 23
Anorexia 42 20 17 22
Stomatitis 89 22 32d 22
Dysgeusia 36 21 20
Erythema 17 21
a

Nausea and vomiting combined.

b

Asthenia and fatigue combined.

c

Only grade 3 and higher reported.

d

Stomatitis and mucosal inflammation.

net = neuroendocrine tumour; gist = gastrointestinal stromal tumour; rcc = renal cell cancer; nsclc = non-small-cell lung cancer.